| http://www.w3.org/ns/prov#value | - Most of the antileishmanial drugs currently in use for treatment, from the long time established antimonials to the recently introduced miltefosine, have disadvantages, such as patient toxicity, side effects and/or parasite resistance [9].Lead discovery is currently one of the bottlenecks in the pipeline for novel antileishmanial drugs [10].
|
